CAS: 1032823-75-8 - GSK1292263
- Sinonimi:
- Gsk-1292263
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | GSK1292263 REF: TM-T2701CAS: 1032823-75-8 | 98.34% - 99.46% | 34,00 €~292,00 € | Mar 17 Dic 24 |
 | 3-Isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole REF: 3D-HRB82375CAS: 1032823-75-8 | Min. 95% | Prezzo su richiesta | Mar 21 Gen 25 |
GSK1292263
CAS:1032823-75-8
GSK1292263 is a GPR119 agonist and has been investigated for the treatment of DIABETES MELLITUS, …
Formula:
C23H28N4O4S
Purezza:
98.34% - 99.46%
Colore e forma:
Solid
Peso molecolare:
456.56
Ref: TM-T2701
| 2mg | 34,00 € | ||
| 5mg | 49,00 € | ||
| 10mg | 81,00 € | ||
| 25mg | 126,00 € | ||
| 50mg | 203,00 € | ||
| 100mg | 292,00 € | ||
| 1mL*10mM (DMSO) | 51,00 € |
Consegna stimata in Stati Uniti, il Martedì 17 Dicembre 2024
3-Isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
CAS:1032823-75-8
3-Isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole is a drug that has been shown to have a constant effect on pluripotent …
Formula:
C23H28N4O4S
Purezza:
Min. 95%
Peso molecolare:
456.56 g/mol
Ref: 3D-HRB82375
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025
